Sci Show: T-ALL leukemia is an aggressive cancer type that mostly affects children. The standard treatment is chemotherapy, but about one in four patients do not respond or develop resistance. Now, researchers have found a combination treatment that could benefit these patients and increase the survival rate.

Tuesday, May 11, 2021

T-ALL leukemia is an aggressive cancer type that mostly affects children. The standard treatment is chemotherapy, but about one in four patients do not respond or develop resistance. Now, researchers have found a combination treatment that could benefit these patients and increase the survival rate.

https://ift.tt/3fdR7zq via /r/science https://ift.tt/3ezMD7h

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)